2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$36.38+$0.05 (+0.14%)
Price as of Aug 03, 2026 4:01 AM EDT- $768.0MMarket Cap
- 40.89%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$36.38+$0.05 (+0.14%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.33 | ||
Change | -$0.12 (-0.33%) | ||
Open | $36.19 | ||
High | $36.58 | ||
Low | $35.31 | ||
Previous Close | $36.45 | ||
Volume | 205,472 | ||
30-Day Average Volume | 264,726 | ||
1-Week Change | 6.74% | ||
1-Month Change | 15.70% | ||
1-Year Change | 40.89% | ||
3-Year Change | 168.92% | ||
5-Year Change | 74.19% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.4B | ||
Market Cap | $768.0M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $383.5M | ||
Net Income | $24.0M | ||
Free Cash Flow | $890,000.00 | ||
EBIT | $42.7M | ||
EBITDA | $55.2M | ||
Net Working Capital | $612.2M | ||
EPS | $0.59 | ||
Enterprise Value/EBITDA | 26 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 62 | ||
PEG | -5 | ||
Price/Free Cash Flow | 860 | ||
Price/Operating Cash Flow | 47 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.32% | ||
Trailing Annual Dividend Yield | 1.32% | ||
Ex-Dividend Date | 09/02/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Annual Dividend Yield